Related Experiment Videos

Statin use and neurologic morbidity after coronary artery bypass grafting: A cohort study

M A Koenig1, M A Grega, M M Bailey

  • 1Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. mkoenin1@jhmi.edu

Neurology
|November 13, 2009
PubMed

Insights

Preoperative statin use did not reduce stroke or encephalopathy after coronary artery bypass grafting (CABG). This large study found no significant benefit for these neurological complications in patients taking statins before heart surgery.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Preoperative statin use is linked to better outcomes in vascular surgery.
  • Its impact on stroke and encephalopathy after coronary artery bypass grafting (CABG) remains uncertain.

Purpose of the Study:

  • To investigate the association between preoperative statin use and the incidence of stroke and encephalopathy in isolated CABG patients.

Main Methods:

  • A 10-year retrospective analysis of prospectively collected data from 5,121 isolated CABG patients.
  • Propensity score analysis was used to adjust for confounding factors.
  • Primary outcomes included stroke and encephalopathy; secondary outcomes were cardiovascular mortality, myocardial infarction, and length of stay.

Main Results:

  • 54% of patients used statins preoperatively. The incidence of stroke was 3.2% and encephalopathy was 8.6%.
  • Propensity score-adjusted analysis showed no significant difference in the odds of stroke or encephalopathy between statin users and non-users (OR 0.958, P=0.674).
  • No significant differences were observed in cardiovascular mortality, myocardial infarction, or length of stay.

Conclusions:

  • Preoperative statin use was not associated with a reduced incidence of stroke and encephalopathy following coronary artery bypass grafting in this cohort.
  • Further research may be needed to clarify the role of statins in mitigating neurological complications after cardiac surgery.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...